| William R Wink, CRNA | |
|
329 Maine St, Brunswick, ME 04011-3310 | |
| (207) 373-2000 | |
| Not Available |
| Full Name | William R Wink |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 329 Maine St, Brunswick, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871555235 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | AA083026 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William R Wink, CRNA 329 Maine St, Brunswick, ME 04011-3310 Ph: (207) 373-2000 | William R Wink, CRNA 329 Maine St, Brunswick, ME 04011-3310 Ph: (207) 373-2000 |
News Archive
Smokers who've received a clean bill of health from their doctor may believe cigarettes haven't harmed their lungs. However, researchers at Weill Cornell Medical College have found that even smokers who seem healthy have damaged airway cells, with characteristics similar to cells found in aggressive lung cancer.
Researchers at Northwestern University, USA, analyzed "long hauler" patients whose symptoms lasted at least six weeks. They found persistent neurological symptoms, including brain fog and headache.
Combination therapy with both BRAF inhibitor vemurafenib and MEK inhibitor cobimetinib achieves greater progression-free survival and response rates than vemurafenib plus placebo in BRAF-mutation positive melanoma, according to phase III data presented at the ESMO 2014 Congress in Madrid, Spain.
Cascades of genetic signals determine which neurotransmitter a brain cell will ultimately use to communicate with other cells. Now a pair of reports from biologists at the University of California, San Diego, have shown for the first time that electrical activity in these developing neurons can alter their chemical fate-and change an animal's behavior-by tweaking this genetic program.
Lux Biosciences, Inc. today announced that the U.S. Food and Drug Administration's Center of Drug Evaluation and Research has issued a Complete Response letter regarding the New Drug Application (NDA) for Luveniq™ (oral voclosporin) for the treatment of non-infectious uveitis.
› Verified 9 days ago
Elizabeth Burgess Hawksley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 123 Medical Center Dr, Brunswick, ME 04011 Phone: 207-373-6000 | |
Michael Grela, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 123 Medical Center Dr, Brunswick, ME 04011 Phone: 207-373-6000 | |
Kirsten E Schrage, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 123 Medical Center Dr, Brunswick, ME 04011 Phone: 207-661-2018 | |
Abigail Kristine Madeira, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 123 Medical Center Dr, Brunswick, ME 04011 Phone: 207-373-6000 | |
Laura Walsh, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 123 Medical Center Dr, Brunswick, ME 04011 Phone: 207-356-0099 |